ArticleInternational journal of molecular sciences2024

Endogenous Signaling Molecule Activating (ESMA) CARs: A Novel CAR Design Showing a Favorable Risk to Potency Ratio for the Treatment of Triple Negative Breast Cancer.

Mira Ebbinghaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.